Search Results 1201-1210 of 18077 for multiple%20sclerosis
ement disorder, Huntington's disease, Multiple ... sclerosis, Myasthenia gravis, Amyotrophic lateral sclerosis, ... ... 20nervous%20system%20disorders&alt ...
... 20, including patients with MSA of either subtype (MSA-P or MSA-C). Patients at the early stages of the disease, defined as a maximum of 5 years since the ...
... multiple system atrophy (MSA), progressive supranuclear palsy (PSP), cortico-basal degeneration (CBD), and other even rarer forms of neurodegeneration. A ...
This is a phase 1b study evaluating a combination of PEGPH20 and pembrolizumab in hyaluronan-high (HA-high) subjects with relapsed/refractory Non-Small Cell ...
CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis. ... 20. View PubMed ... 2020 Jan; 20 (1):74-78 Epub 2019 Nov 27. View ...
December 12, 2017. Study identifies barriers to transplant therapy to treat multiple myeloma among racial minority groups featured image. Cancer. Study ...
rehabilitation, Parkinson's disease, Concussion, Brain cancer, Brain tumor, Multiple sclerosis, Muscular dystrophy, Balance problem, Dystonia, Movement ...
The primary purpose of this study is to understand the influence of sex and gender on pathophysiologic mechanisms of neurodegeneration in Multiple System ...
May 20, 2014. Cancer. Mayo Clinic First to Show Virotherapy is Promising Against Multiple Myeloma (pkg). Robert Nellis. May 16, 2014. Minnesota. Mayo Study ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.